Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cancer Immunotherapy & Biofluid Biopsies 2016

Carmen Gerlach's Biography



Carmen Gerlach, Researcher, Harvard Medical School

Carmen Gerlach received her PhD from Leiden University in the Netherlands for work she performed at the Netherlands Cancer Institute in Amsterdam under guidance of Ton Schumacher. She is currently a research fellow in the lab of Ulrich von Andrian in the Department of Microbiology and Immunobiology at Harvard Medical School. Her research focuses on the differentiation, function, lineage relationships and migration patterns of distinct subsets of memory CD8 T cells.

Carmen Gerlach Image

CX3CR1 Distinguishes Three Distinct Migratory Memory CD8 T-cell Subsets

Wednesday, 2 November 2016 at 15:00

Add to Calendar ▼2016-11-02 15:00:002016-11-02 16:00:00Europe/LondonCX3CR1 Distinguishes Three Distinct Migratory Memory CD8 T-cell SubsetsCancer Immunotherapy and Biofluid Biopsies 2016 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

CD8+ T cells are crucial for the protection against tumors and intra-cellular pathogens via their ability to generate long-term memory. Memory T cells are however not a homogeneous population. Traditionally, they have been sub-divided into central memory (TCM), effector memory (TEM) and tissue-resident memory (TRM) cells based on different migration behaviors and cytotoxic potential.
We recently discovered the existence of a novel subset of memory CD8+ T cells that has unique migratory properties and a superior homeostatic self-renewal capacity. It is tempting to speculate that this subset may be an interesting population in the context of vaccination or adoptive T cell therapy.


Add to Calendar ▼2016-11-01 00:00:002016-11-02 00:00:00Europe/LondonCancer Immunotherapy and Biofluid Biopsies 2016Cancer Immunotherapy and Biofluid Biopsies 2016 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com